Certified by Founder
Lodge
Indapta Therapeutics
start up
United States
- Seattle & Houston
- 18/12/2024
- Unknown
- $22,500,000
Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.
- Industry Biotechnology
- Website https://indapta.com/
- LinkedIn https://www.linkedin.com/company/indapta-therapuetics/
Neros Technologies | $75,000,000 | (Nov 11, 2025)
Spectral Compute | $6,000,000 | (Nov 11, 2025)
TRIP | $40,000,000 | (Nov 11, 2025)
CampusKnot | $1,100,000 | (Nov 11, 2025)
Uare.ai | $10,300,000 | (Nov 11, 2025)
BITE Data | $2,500,000 | (Nov 11, 2025)
EVE(1) | $2,000,000 | (Nov 11, 2025)
Upward Financial | $8,000,000 | (Nov 11, 2025)
IDL (International Dance League) | $7,000,000 | (Nov 11, 2025)
Fastbreak AI | $40,000,000 | (Nov 11, 2025)
The Beans | $5,400,000 | (Nov 11, 2025)
NextSense, Inc | $16,000,000 | (Nov 11, 2025)